General Fusion began Nasdaq trading with about $150m in reported cash. The money can finance experiments and disclosure. A power plant remains a much larger undertaking.
Fusion has acquired a stock ticker before it has acquired a commercial watt. General Fusion began trading on Nasdaq under GFUZ on July 13 after completing its combination with Spring Valley Acquisition Corp. III. The company says it entered the market with about $150m in cash. That is a genuine financing milestone for the field. It is not an energy milestone.
A public listing changes the institution around the experiment. A fusion developer financed largely in private can choose when and how to describe progress. A listed company must file regular financial disclosures, explain material risks and face a market that reprices its promises every day. Public equity may broaden access to fusion’s upside. It also imports the short calendar of quarterly scrutiny into a programme governed by plasma physics.
What investors are funding is the Lawson programme, not construction of a power station. General Fusion says the new cash should carry that programme through several technical milestones it aims to complete in 2028. Its own cautionary language is useful: the company may never generate revenue, may fail to achieve the LM26 objectives and may require additional capital. Those are not boilerplate inconveniences. They describe the central uncertainty of the business.
The phrase funded through milestones also needs care. About $150m must support people, experiments, machine changes and the costs of being public. The company’s engineering runway will therefore depend on spending discipline and on whether each tranche of work produces evidence strong enough to secure follow-on capital on acceptable terms.
The GFUZ evidence ledger
| Item | What is established | What comes next |
|---|---|---|
| Public listing | GFUZ began Nasdaq trading on July 13, 2026 | Regular filings, audited results and market disclosure |
| Cash | About $150m reported at the market debut | Reconciliation in filings, cash use and any further capital |
| LM26 heating | Company reports about 0.72 keV; a preprint reports compressional heating | Peer review, independent scrutiny and reproducible performance |
| 1 keV | A stated programme milestone, not yet reported as achieved | Measured electron temperature at or above the threshold |
| 10 keV and Lawson | Stated later goals | Experimental evidence at declared system boundaries |
| Commercial power | Not demonstrated | Net electricity, repetition, maintainability and competitive economics |
LM26 has produced evidence worth examining. A June preprint covering its first 11 compression shots reports more than a threefold increase in electron temperature, tenfold increases in electron density and poloidal magnetic field, and a rise in neutron flux. Its integrated model attributes most of the temperature increase to compression. General Fusion separately reports an electron temperature of about 0.72 kiloelectronvolts. The paper has not yet been peer reviewed, and the reported result remains below the company’s next stated milestone of 1 keV.
The later rungs are much higher. General Fusion describes 10 keV and, ultimately, the Lawson criterion as programme goals. LM26 has not demonstrated either. It has not demonstrated net fusion energy, net electricity, plant availability or an economical route to repeated operation. Calling the machine commercially relevant is therefore a company description of scale and intent, not a verdict on commercial readiness.
Temperature also sits inside a coupled physics account. A hotter plasma can still be far from useful fusion if density and confinement do not combine at the required level. Beyond that boundary lie repetition, energy recovery, liquid-metal handling, tritium systems, maintainability and the conversion of heat into saleable power. A disciplined assessment should follow all of these ledgers rather than allowing progress on one coordinate to stand in for the system.
The platform question is what public capital helps the company learn. Useful progress would include reproducible shots, peer-reviewed analysis, diagnostics that constrain the model, components that survive repeated compression and a ledger showing how each experiment retires a plant-level risk. A ticker can finance those capabilities. It cannot substitute for them.
General Fusion’s debut is still consequential. Laboratories, private funding rounds and public filings will all test fusion claims. The filings expose cash, dilution, risk and missed milestones. The first service public markets can provide the field is a more legible record.